← Leaderboards
Tetsuro Wakatsuki
Invivo Sciences, Llc.
$7,678,429
Attributed
$9,011,235
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2006–22$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$9,011,235 · 9
By mechanism
R44$4,186,316 · 2
R43$2,734,220 · 5
R01$1,999,209 · 1
R41$91,490 · 1
Top collaborators
- Elliot L. Elson4 shared
- Guy M Genin4 shared
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesPhenotypeCardiacHeartCardiac MyocytesCellsFibroblastsResponsePharmaceutical PreparationsBaseDrug DiscoveryDrug CandidateScreeningEngineeringIn VitroMyocardiumSamplingPhysiologicalContractsLeadPropertyCouplingInduced Pluripotent Stem CellHeart Failure
Grant awards (22)
Diagnostic Tools for Targeted Heart Failure Treatments$493,728
R43 · FY2022 · HL · contact PI
HLS-Cardiac Safety AI Trained Human Heart and Micro Heart Model$861,204
R44 · FY2020 · HL · contact PI
HLS-Cardiac Safety AI Trained Human Heart and Micro Heart Model$881,652
R44 · FY2019 · HL · contact PI
HLS-Cardiac Safety AI Trained Human Heart and Micro Heart Model$349,385
R44 · FY2018 · HL · contact PI
Aging Heart Modeling with Progeria iPSCs$288,459
R43 · FY2018 · AG · contact PI
An Aging Heart Model for Drug Discovery$139,836
R43 · FY2018 · AG · contact PI
An Aging Heart Model for Drug Discovery$176,368
R43 · FY2017 · AG · contact PI
Engineered Tissue Based Phenotypic Screening of Mixture based Libraries$350,000
R43 · FY2016 · AG · contact PI
An Aging Heart Model for Drug Discovery$177,723
R43 · FY2016 · AG · contact PI
Engineered Tissue Based Phenotypic Screening of Mixture based Libraries$58,660
R43 · FY2016 · AG · contact PI
THE EFFECTS OF MYOFIBROBLASTS ON ELECTROMECHANICAL FUNCTION OF MODEL HEART TISSUE$491,565
R01 · FY2015 · HL
Engineered Tissue Based Phenotypic Screening of Mixture based Libraries$350,000
R43 · FY2015 · AG · contact PI
MASS PRODUCTION OF PERSONALIZED HUMAN ENGINEERED HEART TISSUES$349,446
R43 · FY2015 · GM · contact PI
Engineered tissue-based, high-throughput compound profiling$10,764
R44 · FY2015 · GM · contact PI
THE EFFECTS OF MYOFIBROBLASTS ON ELECTROMECHANICAL FUNCTION OF MODEL HEART TISSUE$489,071
R01 · FY2014 · HL
MASS PRODUCTION OF PERSONALIZED HUMAN ENGINEERED HEART TISSUES$350,000
R43 · FY2014 · GM · contact PI
Engineered tissue-based, high-throughput compound profiling$1,030,123
R44 · FY2013 · GM · contact PI
THE EFFECTS OF MYOFIBROBLASTS ON ELECTROMECHANICAL FUNCTION OF MODEL HEART TISSUE$475,096
R01 · FY2013 · HL
Engineered tissue-based, high-throughput compound profiling$886,967
R44 · FY2012 · GM · contact PI
THE EFFECTS OF MYOFIBROBLASTS ON ELECTROMECHANICAL FUNCTION OF MODEL HEART TISSUE$543,477
R01 · FY2012 · HL
Engineered tissue-based, high-throughput compound profiling$166,221
R44 · FY2012 · GM · contact PI
High Throughput Profiling of Plant Extracts Using Engineered Heart Tissues$91,490
R41 · FY2006 · AT · contact PI